SuperworthWhitehawk Therapeutics shares outstanding WHWK
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 82.9M
- On a year earlier
- +20.0%
- more shares
Whitehawk Therapeutics had 82.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 20.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 69.2M | +156% |
| FY2024 | 27.1M | +0% |
| FY2023 | 27M | +0% |
| FY2022 | 26.8M | +28% |
| FY2021 | 20.9M | +722% |
| FY2020 | 2.5M | −100% |
| FY2019 | 1.2B | +0% |
| FY2018 | 1.2B | +51% |
| FY2017 | 809M | +2705% |
| FY2016 | 28.8M | −81% |
| FY2015 | 150M | +0% |
| FY2014 | 150M | +0% |
| FY2013 | 150M | +0% |
| FY2012 | 150M | +0% |
| FY2011 | 150M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 82.9M | +20% | |
| Q1 FY26 | 69.2M | +73% | |
| Q4 FY25 | 69.2M | +156% | |
| Q3 FY25 | 69.2M | +156% | |
| Q2 FY25 | 69.1M | +156% | |
| Q1 FY25 | 39.9M | +48% | |
| Q4 FY24 | 27.1M | +0% | |
| Q3 FY24 | 27M | +0% | |
| Q2 FY24 | 27M | +0% | |
| Q1 FY24 | 27M | +0% | |
| Q4 FY23 | 27M | +0% | |
| Q3 FY23 | 26.9M | +27% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Whitehawk Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.